Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the commonest non-Hodgkin lymphoma. Previous studies examining the cost of treating DLBCL have generally focused on a specific first-line therapy alone; meaning that their findings can neither be extrapolated to the general patient population nor...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Health Econ
Hlavní autoři: Wang, Han-I., Smith, Alexandra, Aas, Eline, Roman, Eve, Crouch, Simon, Burton, Cathy, Patmore, Russell
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Berlin Heidelberg 2016
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5313581/
https://ncbi.nlm.nih.gov/pubmed/26969332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10198-016-0775-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky